Explore Products

Acute Coronary Syndrome (ACS)

Product Overview

Acute Coronary Syndrome (ACS) Application is aimed at unit directors and medical directors; operational directors; clinical improvement teams; and emergency, intensive care, and inpatient care units focused on outcomes improvement for patients presenting with ACS. The application focuses on providing data to help improve rapid diagnosis of STEMI and NSTEMI patients; NSTEMI risk stratification into high, moderate, and low risk categories; and ED and inpatient management of all patients with ACS. In-Development

Download Datasheet


Benefits Include:

  • Improved mortality outcomes by appropriate stratification into ACS probability categories.
  • Reduce LOS by appropriate risk stratification and management.
  • Decreased cost per case and length of stay.

See Sample Screenshots of Acute Coronary Syndrome (ACS)

Data Sources

  • EMR
  • Costing

Acute Coronary Syndrome: A Deeper View


Acute Coronary Syndrome refers to a constellation of clinical symptoms related to acute myocardial infarction and includes ST-segment elevation myocardial infarction (STEMI), unstable angina, and non-ST segment elevation myocardial infraction (NSTEMI). Total discharges for ACS from US hospitals in 2009 was 1,190,000 patients (Roger 2012). This number has only increased due to factors such as high obesity rates and sedentary lifestyle. Correct diagnosis and treatment is difficult and significant variations in care are well recognized making this a condition that healthcare providers should be prioritizing for outcome improvements.

(Roger, V.L., Go, A.S., Lloyd-Jones, D.M., Benjamin, E.J., et al. 2012. Heart disease and stroke statistics – 2012 update: A report from the American Heart Association. Circulation. DOI: 10:1161/CIR.0b013e31823ac046.)

Success Measures

Opportunity Identification:

  • Increase risk stratification of NSTEMI patients into appropriate treatment categories.

Process Improvements:

  • Improve ED door to ECG time.
  • Improve ED door to balloon time in STEMI patients.
  • Improve rapid utilization of TIMI scores and Troponin-1 testing in NSTEMI patients.
  • Appropriately risk stratify NSTEMI patients to appropriate ACS probability category.
  • Identify compliance to initial medications and treatment recommendations.

Outcomes Improvement:

  • Lower mortality rate for ACS patients
  • Reduce average length of stay for ACS patients
  • Reduce rate of readmission for ACS patients

Problem Summary

Health Catalyst ranks ACS among top 10 care processes representing opportunities for improvement, based on volume, variation, and financial metrics. Health systems often struggle to implement best practices shown to improve morbidity, mortality, length of stay, and readmissions. These organizations can benefit from analytics that help them focus on their performance in key areas such as rapid diagnosis, risk stratification, and appropriate intervention.